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Abstract 
When the expression levels of nucleoside diphosphate (NDP) kinase/nm23 were examined in four human normal diploid fibroblast cell lines in 
comparison with their corresponding immortalized cells transformed by SV40 large T antigen or “Co irradiation, mRNA levels of the two isoforms 
(NDP kinase A/nm23-Hl, NDP kinase B/mn23-H2) were increased in the immortalized cell lines. The increase was found to be associated with 
increased translation products. Furthermore, the cell extracts prepared from these immortalized cell lines demonstrated slightly higher enzyme activity 
than those from their normal counterparts. Neither the growth state nor the in vitro aging largely affected their expression in a normal cell line (TIG-3) 
examined. The results suggest possible involvement of NDP kinases/nm23 in acquiring an infinite growth property of these cells. 
1. Introduction 
Nucleoside diphosphate (NDP) kinase is a ubiquitous 
enzyme that has been believed to play a housekeeping 
role through catalyzing transphosphorylation of nucleo- 
side diphosphates to produce corresponding tri- 
phosphate nucleotides [l]. The enzyme is now known to 
be multifunctional [2-4]; it is identical to nm23 (a candi- 
date tumor metastasis uppressor) [5,6], Awd (a morpho- 
logical regulator in Drosophila) [7], I-factor (a differenti- 
ation inhibitor of mouse myeloid leukemia cell) [8] and 
PuF (a transcription factor of human c-myc gene) [9]. 
Among these functions, the latter two do not require the 
enzyme activity to elicit their actions [lo], whereas Awd 
function seems to be associated with the enzyme activity 
[7]. Whether the action of nm23 parallels the enzyme 
activity remains uncertain, but a recent report describes 
that serine phosphorylation rather than enzyme activity 
may be associated with the antimetastatic potential of 
nm23 [ll]. 
Growth associated increase in either the enzyme activ- 
ity or its transcript levels of NDP kinase has been docu- 
mented for fission yeast Schizosaccharomyces pombe 
[12], slime mold Dictyostelium discoideum [ 131, mouse 
[14] and human [15] cells. This leads to the speculation 
that the enzyme may function in association with growth 
property of the cell. A recent finding [ 161 that microinjec- 
tion of an NDP kinase/nm23 antibody into rat embryo 
fibroblasts inhibited cell division with no apparent effect 
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on DNA synthesis is an additional support for such no- 
tion. However, the relationship between NDP kinase ex- 
pression and cell growth property is not straightforward. 
For example, we [17] recently observed that overexpres- 
sion or disruption of a Saccharomyces cerevisiae YNK 
gene that encodes NDP kinase affected neither growth 
rate nor spore formation. Further, a recent report [18] 
describes that increased levels of nm23-Hl mRNA in 
proliferative phase of cancer cell growth were not accom- 
panied by definite changes in the translation product. In 
this study we investigated whether the expression of 
NDP kinase/mn23 is related to an acquisition of the 
infinite cell growth property of normal human diploid 
cells in terms of the transcription and translation prod- 
ucts, and the enzyme activity. 
2. Materials and Methods 
2.1. Cells and cell culture 
Four human normal diploid fibroblasts (TIG-3 1191, KMS-6 1201, 
WI-38 [21] and IMR-90 [i2]) and their corresponding immortai&ed 
cells (TIG-3SVts. KMST-6. WI-38VAl3. and IMR-90SV) were used. 
Population doubling levels (PDL) of normal cell lines!‘methods of 
transformation and doubling time of these cell lines are listed in Table 
1. All of these transformed cells were unable to form colonies when 
cultured on soft agar plates. Cells were maintained in Eagle’s minimal 
essential medium (MEM, Nissui Pharmaceutical Co. Ltd., Tokyo) sup- 
plemented with kanamysin and 10% fetal bovine serum in a humidified 
atomosphere of 5% CO, and 95% air. The cells were grown at 37°C 
except TIG-3SVts which was cultivated at 34°C. 
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2.2. Preparation of cell extracts and NDP kinase assay 
Subconfluent cells in 100 mm culture dishes were detached by 0.25% 
trypsin, rinsed three times with ice-cold Dulbecco’s phosphate buffered 
saline and lysed with 0.8 ml of 0.5% sucrose monolaurate (Mitsubishi 
Kasei Kogyo Co. Ltd.) in STME buffer (0.25 M sucrose, 10 mM 
Tris-HCI, pH 7.4, 2 mM MgCl,, 1 mM EDTA). NDP kinase activity 
All rights reserved. 
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was determined by pyruvate kinase-lactate dehydrogenase coupled en- 
zyme system as described previously [23]. 
2.3. Immunoblotting 
The cell extracts (15 mg of protein) were subjected to SDS-PAGE and 
then electrophoretically transferred to a PVDF (polyvinylidene dif- 
luoride) membrane (Bio-Rad). The membrane was treated with affinity 
purified anti-rat NDP kinase rabbit polyclonal antibody (NK-2) that 
reacts specifically with human [24] as well as rat [23,25] NDP kinases, 
followed by peroxidase conjugated anti-rabbit IgG, and detection was 
carried out using an ECL assay kit (Amersham). 
2.4. RNA extraction and Northern blotting 
Total cellular RNA was prepared from cells in a 100 mm culture dish 
using 1.5 ml of Isogen (Wake Pure Chemicals), a modified extraction 
solution of single-step purification [26]. 15 pg of RNA was electro- 
phoresed on a 1% agarose gel and transferred to a nitrocellulose mem- 
brane after separation. Hybridization was performed with either a 
full-length nm23-Hl (NDP kinase A) or nm23-H2 (NDP kinase B) 
cDNA probe labeled by the random priming method essentially as 
previously described [4]. The filters were washed with 2 x SSC/O.Z% 
SDS, followed by two times washing with 0.2 x SSC/O.2% SDS at 65°C 
for 30 min. 
3. Results 
The immortalized human cells obtained by transfor- 
mation with SV40 large T antigen or 6oCo irradiation 
were all morphologically of transformed phenotype and 
neither of them showed anchorage independent growth 
properties. So far, two isoforms of NDP kinase/nm23 
have been identified in human [27] as well as rat [4] and 
mouse [28]. Northern blot analyses (Fig. 1) revealed that 
mRNA levels of both isoforms were concomitantly ele- 
vated in the immortalized cells; especially an increase in 
the NDP kinase-A/nm23-Hl mRNA was dramatic in the 
immortalized cells except WI-38VA13 cell. Neither the 
growth state (log phase or stationary phase) nor serum 
A. NDPK-A/nm23-Hl 
TIG-3 WI-38 
KMS-6 IMR-90 
NnT E Nr! Nq 
deprivation (from 10% to 0.5%, and serum refeeding 
also) largely altered these transcript levels when exam- 
ined with TIG-3 cell (not shown). It is known that nor- 
mal human diploid cells cease to grow after a limited 
number of PDL. In an attempt to know the effect of in 
vitro aging on the expression of NDP kinase, we com- 
pared these transcripts levels of normal and immmortal- 
ized TIG-3 cells with different PDL (normal: 17.6 vs. 
59.3 PDL; immortalized: 178 vs. 303 PDL) (Fig. 2). The 
results demonstrated that the transcripts levels were es- 
sentially the same between the cell lines with different 
PDL in both groups. It seems therefore that the levels of 
NDP kinases/nm23 transcripts fluctuate in relation to 
infinite growth property (immortalization) of the human 
fibroblasts rather than their growth state or in vitro 
aging (PDL) of the cells. 
Whether the increased levels of nm23 transcripts are 
accompanied by those of translation products and en- 
zyme activity was further examined. Western blot analy- 
sis with an affinity purified anti-rat NDP kinase anti- 
body (NK-2) identified a doublet with 18 kDa major 
protein band (Fig. 3). In agreement with the data on the 
mRNA levels, all these transformed cell lines contained 
more NDP kinase protein than did their parental normal 
counterparts although the difference seemed smaller in 
each case than that of the transcript level. Moreover, 
small but significant difference was also observed for the 
NDP kinase enzyme activity (Fig. 4). The enzyme activ- 
ity present in the normal cell extracts varied between 
3.8-5.7 mmol/mg protein/min. Nevertheless, the activi- 
ties in the immortalized cell extracts were consistently 
higher than those in their normal counterparts (l&38% 
increase). It seemed unlikely that NDP kinase activity is 
correlated with doubling time of these cells (see Table 1). 
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Fig. 1. Northern blot analyses of NDP kinase (nm23) transcription products from normal and immortalized human fibroblasts. Total RNAs (15 
pg each) from cultured human cell lines were separated on a 1% agarose gel and transferred onto a nitrocellulose membrane. Hybridization with 
either nm23-HlfNDP kinase A (A) or nm23-H2/NDP kinase B (B) cDNA probe was carried out as described in the text. N = normal cells; 
T = corresponding immortalized, transformed cells. Strong ladder bands, which are present in higher position compared with that of nm23-Hl (NDP 
kinase A) in IMR-90 SV cells but not in other cells, seem unlikely to be physiologically relevant, since the Western blot data provided neither extra 
protein bands nor extremely strong signal at the expected size (18 kDa). 
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Fig. 2. Expression of NDP kinase (nm23) mRNAs in normal TIG3 and immortalized TIG-3SVts cells with different PDL. Total RNAs from normal 
TIG-3 with 17.6 PDL (lanes 1 and 5) and 59.3 PDL (lanes 2 and 6), and those from immortalized TIG-3SVts with 178 PDL (lanes 3 and 7) and 
303 PDL (lanes 4 and 8) were used and analyzed as described in Fig. 1 
4. Discussion 
Some biochemical and immunohistochemical studies 
from this and other laboratories on the behavior of NDP 
kinase/nm23 of cancer tissues from human and other 
Western Blotting 
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Fig. 3. Western blot analyses of NDP kinases from human normal and 
immortalaized cultured cells. The cell extracts (1.5 pg protein each) from 
normal and immortalized human fibroblasts were electrophoresed on 
a SDS-PAGE gel, followed by electrophoretic transfer onto a PVDF 
membrane and immunodetection by an aflinity purified anti-rat NDP 
kinase rabbit antibody. N = normal cells; T = corresponding immortal- 
ized, transformed cells. 
origins provided an indication that not all but most can- 
cer tissues including human breast cancers seem to be 
associated with enhanced expression of NDP kinase/ 
nm23 compared with neighboring normal tissues [29- 
32]. Such observations led us to speculate that the NDP 
kinase/mn23 expression may alter in association with an 
early step of the tumorigenic processes in addition to 
metastatic phenotype of the cell. The present study dem- 
onstrated for the first time that the expression of NDP 
kinase/nm23 is potentiated in human fibroblasts with 
infinite cell growth potential. The expression did not 
change depending on the growth state or in vitro aging 
of the cells. Although the alteration of the enzyme activ- 
ity was smaller than that of the transcript levels, the 
observation seems important because, in most other 
cases so far examined, detection of such altered enzyme 
activity (or protein level) has been rare even under the 
condition where their transcript levels changed drasti- 
cally [11,18]. It should be noted, however, that WI- 
38VA13 cell showed significant increased levels of the 
protein amount and enzyme activity despite insignificant 
change in the transcripts levels. This observation was 
unexpected and remains to be investigated further. Con- 
sidering the fact that neither of the immortalized cell 
lines used in this study possessed anchorage independent 
growth property, NDP kinases/nm23 (probably through 
their enzyme activity) seem to be involved in an early 
phase of tumorigenic processes. 
Normal human diploid cells can proliferate in in vitro 
culture systems but die after a limited number of PDL. 
These cells acquire infinite growth property after trans- 
formation and then undergo tumorgenic alterations, Re- 
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Fig. 4. NDP kinase activity in the extracts from normal and immortal- 
ized human fibroblasts. The cell extracts were prepared as described in 
section 2 and the enzyme activity was determined by the pyruvate 
kinase-lactate dehydrogenase coupled enzyme assay method. Open col- 
umns = normal cells; hatched columns = corresponding immortalized, 
transformed cells. The values are means f standard errors (vertical 
bars). Similar results were obtained from three independent experi- 
ments and the representative data are shown. 
cent studies revealed that the former process (immortali- 
zation) can be achieved by the participation of at least 
four complementary recessive factors [33]. These factors 
are suggested to include tumor suppressor gene prod- 
ucts, such as, Rb and ~53 [34,35]. In view of the fact that 
the immortalized human cell lines used in this study ex- 
cept KMST-6 cell were transformed by SV-40 large T 
antigen that is known to bind and inactivate Rb and ~53 
proteins [34-361, the expression of NDP kinases may be 
influenced, directly or indirectly, by these tumor suppres- 
sor gene products. 
Table 1 
Profiles of human normal diploid fibroblasts and their immortalized 
counterparts 
Cells PDL* Doubling time (h) 
Normal cells 
TIG-3 
KMS-6 
WI-38 
IMR-90 
18.3 (21.8%) 24.0 
30.3 (79.1%) 32.2 
25.3 (45.5%) 26.1 
33.3 (47.5%) 26.7 
Immortalized cells 
TIG-3SVts** 
KMST-6*** 
WI-38 VA13** 
IMR-90 SV** 
27.0 
23.1 
21.6 
24.3 
*% lifespan completed. 
**Transformed by SV-40 large T antigen. 
***Transformed by “Co irradiation. 
Two isoforms of mammalian NDP kinases are ex- 
tremely homologous to each other in their amino acid 
sequences [4]; 89% identical in rat and human, for exam- 
ple. Although their specific roles have not been clearly 
demonstrated [25], the observations, such as tissue-de- 
pendent expression of isoforms [4] and preferential de- 
creased expression of one isoform compared with the 
other in highly metastatic ells and tissues [27], may sug- 
gest their respective roles and different expression con- 
trol mechanisms. It should be noted, in this respect, that 
mRNAs of both isoforms were increased in the immor- 
talized cell lines except WI-38VA13. This may suggest a 
common, in addition to independent, regulatory mecha- 
nism of the gene expression for the two isoforms relating 
to an acquisition of infinite cell growth property. 
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